La Trobe
1201074_Luk,I_2022.pdf (7.52 MB)

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

Download (7.52 MB)
Version 2 2023-10-19, 00:37
Version 1 2023-01-16, 05:58
journal contribution
posted on 2023-10-19, 00:37 authored by Ian LukIan Luk, Laura JenkinsLaura Jenkins, Kael Schoffer, Irvin Ng, Janson Tse, D Mouradov, S Kaczmarczyk, Rebecca NightingaleRebecca Nightingale, Allan Burrows, Robin AndersonRobin Anderson, D Arango, H Dopeso, L Croft, MF Richardson, OM Sieber, Yang LiaoYang Liao, JK Mooi, Natalia VukelicNatalia Vukelic, Camilla Marstrander ReehorstCamilla Marstrander Reehorst, S Afshar-Sterle, VLJ Whitehall, L Fennell, HE Abud, Niall TebbuttNiall Tebbutt, WA Phillips, David WilliamsDavid Williams, Wei ShiWei Shi, Lisa MielkeLisa Mielke, Matthias ErnstMatthias Ernst, Amardeep Dhillon, NJ Clemons, John MariadasonJohn Mariadason
Colorectal cancers (CRCs) often display histological features indicative of aberrant differentiation but the molecular underpinnings of this trait and whether it directly drives disease progression is unclear. Here, we identify co-ordinate epigenetic inactivation of two epithelial-specific transcription factors, EHF and CDX1, as a mechanism driving differentiation loss in CRCs. Re-expression of EHF and CDX1 in poorly-differentiated CRC cells induced extensive chromatin remodelling, transcriptional re-programming, and differentiation along the enterocytic lineage, leading to reduced growth and metastasis. Strikingly, EHF and CDX1 were also able to reprogramme non-colonic epithelial cells to express colonic differentiation markers. By contrast, inactivation of EHF and CDX1 in well-differentiated CRC cells triggered tumour de-differentiation. Mechanistically, we demonstrate that EHF physically interacts with CDX1 via its PNT domain, and that these transcription factors co-operatively drive transcription of the colonic differentiation marker, VIL1. Compound genetic deletion of Ehf and Cdx1 in the mouse colon disrupted normal colonic differentiation and significantly enhanced colorectal tumour progression. These findings thus reveal a novel mechanism driving epithelial de-differentiation and tumour progression in CRC.

Funding

This project was supported by NHMRC project grant (1107831), a Cancer Council Victoria Grant (1164674) and the Operational Infrastructure Support Programme, Victorian Government, Australia. JMM was supported by a NHMRC Senior Research Fellowship (1046092). IYL was supported by F J Fletcher Research Scholarship and Randal and Louisa Alcock Scholarship from the University of Melbourne. LJJ was supported by La Trobe University Australian Postgraduate Awards. IN was supported by La Trobe University Postgraduate Research Scholarship. JWTT was supported by the University of Melbourne Australian Postgraduate Awards. OMS is a National Health and Medical Research Council (NHMRC) Senior Research Fellow (APP1136119). Open Access funding enabled and organized by CAUL and its Member Institutions.

History

Publication Date

2022-11-01

Journal

Cell Death and Differentiation

Volume

29

Issue

11

Pagination

15p. (p. 2288-2302)

Publisher

CDD Press

ISSN

1350-9047

Rights Statement

© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.